We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.17%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$86.1B
AUM Growth
-$1.05B
(-1.2%)
Cap. Flow
+$4.86B
Cap. Flow
% of AUM
5.64%
Top 10 Holdings %
Top 10 Hldgs %
27.63%
Holding
2,366
New
101
Increased
1,396
Reduced
686
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.43B |
| 2 |
TotalEnergies
TTE
|
+$626M |
| 3 |
Deutsche Bank
DB
|
+$326M |
| 4 |
Stellantis
STLA
|
+$263M |
| 5 |
Broadcom
AVGO
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$291M |
| 2 |
Apple
AAPL
|
+$262M |
| 3 |
Amazon
AMZN
|
+$219M |
| 4 |
Tesla
TSLA
|
+$205M |
| 5 |
Meta Platforms (Facebook)
META
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
CorMedix
CRMD
$632M
| $10.6K | ﹤0.01% |
1,559
+525
| +51% | +$3.88K |
|
|
HPP
2127
Hudson Pacific Properties
HPP
$807M
| $10.5K | ﹤0.01% |
1,779
+903
| +103% | +$6.93K |
|
2128
Opko Health
OPK
$883M
| $10.5K | ﹤0.01% |
9,221
+3,176
| +53% | +$3.91K |
|
2129
AMC Entertainment Holdings
AMC
$2.04B
| $10.5K | ﹤0.01% |
10,704
+3,603
| +51% | +$4.64K |
|
2130
Penske Automotive Group
PAG
$14.2B
| $10.5K | ﹤0.01% |
70
-37
| -35% | -$5.86K |
|
2131
Skywest
SKYW
$3.82B
| $10.4K | ﹤0.01% |
113
+15
| +15% | +$1.48K |
|
2132
Revolve Group
RVLV
$1.75B
| $10.3K | ﹤0.01% |
+457
| New | +$12K |
|
|
SERV
2133
Serve Robotics
SERV
$429M
| $10.3K | ﹤0.01% |
+1,216
| New | +$13.2K |
|
2134
FTAI Infrastructure
FIP
$519M
| $10.2K | ﹤0.01% |
2,061
+303
| +17% | +$1.7K |
|
2135
Metropolitan Bank Holding Corp
MCB
$1.13B
| $9.91K | ﹤0.01% |
119
+4
| +3% | +$343 |
|
2136
Utz Brands
UTZ
$1.25B
| $9.9K | ﹤0.01% |
1,250
+482
| +63% | +$4.48K |
|
2137
Phathom Pharmaceuticals
PHAT
$925M
| $9.88K | ﹤0.01% |
889
+285
| +47% | +$3.6K |
|
|
ARDT
2138
Ardent Health
ARDT
$1.49B
| $9.85K | ﹤0.01% |
1,151
+580
| +102% | +$5.2K |
|
|
MZTI
2139
The Marzetti Company
MZTI
$2.92B
| $9.82K | ﹤0.01% |
71
-38
| -35% | -$6.05K |
|
2140
Olema Pharmaceuticals
OLMA
$1.03B
| $9.75K | ﹤0.01% |
+654
| New | +$14.6K |
|
2141
US Physical Therapy
USPH
$1.11B
| $9.74K | ﹤0.01% |
130
+20
| +18% | +$1.64K |
|
2142
Fox Factory Holding Corp
FOXF
$765M
| $9.74K | ﹤0.01% |
592
+61
| +11% | +$1.1K |
|
2143
Sinclair Inc
SBGI
$965M
| $9.74K | ﹤0.01% |
753
+278
| +59% | +$4.04K |
|
|
RWT
2144
Redwood Trust
RWT
$614M
| $9.73K | ﹤0.01% |
1,735
+195
| +13% | +$1.13K |
|
2145
Savers
SVV
$1.39B
| $9.71K | ﹤0.01% |
1,305
+323
| +33% | +$3.09K |
|
|
PSIX
2146
Power Solutions International
PSIX
$723M
| $9.62K | ﹤0.01% |
158
-1,460
| -90% | -$104K |
|
2147
Solid Power
SLDP
$484M
| $9.58K | ﹤0.01% |
3,194
+985
| +45% | +$3.97K |
|
2148
indie Semiconductor
INDI
$769M
| $9.54K | ﹤0.01% |
2,964
+683
| +30% | +$2.41K |
|
2149
McEwen Inc
MUX
$1.05B
| $9.54K | ﹤0.01% |
467
+20
| +4% | +$475 |
|
2150
Lindblad Expeditions
LIND
$1.77B
| $9.48K | ﹤0.01% |
+548
| New | +$9.73K |
|
Similar funds
BNP Paribas Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Asset Management held 2,366 positions worth $86.1B, down 1.2% from $87.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BNP Paribas Asset Management deployed $4.86B of net new capital in Q1 2026, opening 101 new positions and adding to 1,396 existing holdings. Its largest new stake was Viking Holdings: 1,864,036 shares worth $137M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ciena, an estimated $291M trimmed.
- BNP Paribas Asset Management's largest Q1 2026 buy was Viking Holdings: 1,864,036 shares worth $137M.
- BNP Paribas Asset Management added most to AstraZeneca in Q1 2026, an estimated $1.43B increase.
- BNP Paribas Asset Management's biggest Q1 2026 reduction was Ciena, cutting an estimated $291M.
- BNP Paribas Asset Management fully exited Exact Sciences in Q1 2026, selling an estimated $35.9M.
- BNP Paribas Asset Management's ten largest holdings make up 28% of its $86.1B portfolio in Q1 2026.
- BNP Paribas Asset Management opened 101 new positions and closed 108 in Q1 2026.
- BNP Paribas Asset Management's portfolio value fell 1.2% quarter-over-quarter to $86.1B.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.